Semi Auto Biochemistry Analyzer Dymind

Dymind DP-C16 Clinical Chemistry & Coagulation Analyzer – Semi-Automatic Biochemistry Analyzer for Comprehensive Diagnostics

The Dymind DP-C16 Clinical Chemistry & Coagulation Analyzer is a high-performance, semi-automatic analyzer designed to meet the diagnostic needs of laboratories and hospitals. This device provides reliable and precise chemistry and coagulation analysis, offering advanced functionality to support a variety of tests for patient care. With a user-friendly 7-inch color touch screen, the DP-C16 model is easy to operate, enhancing workflow efficiency in busy labs.

Key Features:

• Dual Functionality: The DP-C16 model supports both biochemistry and coagulation testing, with dedicated parameters such as PT, APTT, TT, FIB, and D-Dimer.
• Advanced Optical System: It comes with an 8-wavelength optical system (340nm to 660nm), providing both single-wavelength and dual-wavelength detection modes to enhance the accuracy of test results.
• Comprehensive Diagnostic Panels: This analyzer is capable of performing a variety of tests, including renal function panel, general chemistry panel, renal & liver function panel, and specialized tests for myocardial enzymes, diabetes, pancreatitis, blood-gas electrolyte, and blood lipid examinations.
• Precise and Reliable Coagulation Analysis: Utilizing photometry and nephelometry, this system ensures accurate coagulation measurements, critical for assessing clotting disorders and other conditions.
• User-Friendly Interface: The 7-inch touch screen interface makes it easy to operate, allowing for quick setup, calibration, and test execution.
• Compact and Efficient: Manufactured in China, this compact model is designed to fit into a wide range of laboratory environments, ensuring efficient and reliable operation without compromising on accuracy.

Whether you need to perform routine biochemical analysis or specialized coagulation tests, the Dymind DP-C16 provides the versatility and precision needed to ensure accurate patient diagnostics.